BioSpace News Archive

Lannett Company, Inc. announced that the company used a portion of its existing cash on hand to pay off, in full, the remaining $42 million outstanding balance of its Term A Loans.

OraSure Technologies, Inc., a leader in the fight against HIV, announced its plans to commemorate World AIDS Day.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the launch of Anemia ID, a program providing no-cost genetic testing for patients with suspected hereditary anemias

Apellis Pharmaceuticals , Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will present at the 2020 Evercore ISI HealthCONx Conference on Thursday, December 3, 2020 at 1:25 p.m. ET. The conference will be held in a virtual meeting format. Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, will participate in a fireside chat. The event

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a webcast on Monday, December 7, 2020 at 4:30pm EST . Management will discuss data presented at the American Society of Hematology (ASH) 2020 Annual Meeting as well as provide updates on the Company’s broader oncology and hematology portfolio. Conference Call Informati

Cogent Biosciences, Inc. (“Cogent”) (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Brad Barnett as Chief Technology Officer (CTO).

Platelet Rich Plasma therapy is gaining traction in healthcare sector owing to its ability to assist in the healing injuries on patient’s body.

The demand within the global rickets treatment market has been rising on account of advancements in the field of paediatric care.

Microplate systems are used extensively in research and diagnostics, which require quick and high-throughput analysis of the patients.

The report examines the past and current growth scenario in the global hospital infection therapeutics market to present an exhaustive analysis of growth trends and opportunities in the said market for the 2019 – 2029 forecast period.